Partner Headlines - IBB

  1. Making Money With Charles Payne: 05/1/15

    FoxBusiness
  2. Nasdaq Leads Market Lower As Medical Stocks Tumble

    IBD
  3. Technology, Inflation Protection And Biotech ETFs To Watch This ...

    Benzinga
  4. How To Invest In ETFs: Tips To Trade Top Market Trends

    IBD
  5. Social Media Analytics: 3 ETFs Recently Blowing Up On Twitter

    Benzinga
  6. The Best Biotech ETF Isn't Always The Biggest

    Benzinga
  7. Biotech Stocks Moving Higher

    Benzinga
  8. Evercore ISI Technical Analysis: The 'Single Best Idea'

    Benzinga
  9. Top 5 Biotech Stocks That The Smart Money Doesn't Like

    Benzinga
  10. iShares NASDAQ Biotech ETF Pulls Back Off All-Time Highs

    Benzinga
  11. Making Money With Charles Payne: 01/14/15

    FoxBusiness
  12. Are There Any Winners Left In The Biotech Space?

    Benzinga
  13. Biotech Stocks Sell Off, ETFs Fall Over 5%

    Benzinga
  14. Making Money With Charles Payne: 12/22/14

    FoxBusiness
  15. 3 Biotech ETFs Rally On Merger News

    Benzinga
  16. A Look At 3 Overbought ETFs

    Benzinga
  17. 1 Biotech Beast Worth Tracking

    Benzinga
  18. Best And Worst ETFs Of The Week Amid Biotech Breakout

    Benzinga
  19. Arrowhead Research Corp Heads Higher After Breakout

    Benzinga
  20. Biotechnology, Oil And Brazil ETFs To Watch This Week

    Benzinga
  21. Isis Pharmaceuticals Finally Breaks Out

    Benzinga
  22. Yellen Says Social Media, Biotech Stocks 'Substantially Stretched'

    Benzinga
  23. 4 ETFs With Upside Potential

    Benzinga
  24. Dow Closes At A New High As Late-Month Rally Boosts Stocks

    Benzinga
  25. Johnson & Johnson: Why Top Funds Are Buying

    YCharts
  26. Stocks Revisit Session Lows; Share Offer Lifts GasLog

    IBD
  27. Don't Panic Over Recent Tech Turmoil

    FoxBusiness
  28. Despite S&P 500's New High, Stocks Face Challenges

    Benzinga
  29. Biotech ETFs Come Back Down To Earth

    Benzinga
  30. ETF Outlook For Wednesday, March 26, 2014 (IBB, IPO, FPX, SOCL, ...

    Benzinga
  31. ETF Outlook For The Week Of March 24, 2014 (IBB, CARZ, RSX, GM)

    Benzinga
  32. Stocks Edge Lower In Dull Session; Biogen Idec Hangs Tough

    IBD
  33. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  34. Biotech And Natural Gas ETFs On A Roll

    Benzinga
  35. ETF Outlook For The Week Of February 10 (IBB, VXZ, GREK, GDX)

    Benzinga
  36. Sector ETFs Breaking Out (IBB, IHE, XLV, IAT, SKYY)

    Benzinga
  37. ETF Outlook for Friday, December 20 (REM, USO, IBB, FCG)

    Benzinga
  38. The One True Sector Bubble: Profits Here When It Crashes Soon

    Benzinga
  39. ETF Outlook for Tuesday, November 26, 2013

    Benzinga
  40. Biotech ETFs Plummeting (XBI, IBB, BBH)

    Benzinga
  41. Biotech Breakout Highlights Flawed ETF Thinking

    Benzinga
  42. Three Soaring, But Overlooked Health Care ETFs

    Benzinga
  43. Seasonal Trends: Three ETFs To Own In August

    Benzinga
  44. Three ETFs That Have Blown Past Their 200-Day Lines

    Benzinga
  45. ETFs to Watch July 29, 2013 (BOND, EWJ, IBB)

    Benzinga
  46. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga
  47. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga
  48. Use The Sharpe Ratio For Profits With These ETFs

    Benzinga
  49. 4 Health Care ETFs Your Broker Forgot to Mention

    Benzinga
  50. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga
  51. These ETFs Are Awash in 2013 Takeover Targets

    Benzinga
  52. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga
  53. Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

    Benzinga
  54. S&P Likes a Trio of Biotech ETFs

    Benzinga
  55. ETFs to Watch October 23, 2012 (FCF, IBB, EWT)

    Benzinga
  56. Investors Cheating Themselves by Focusing on Largest ETFs

    Benzinga
  57. Three Biotech Stocks Analysts Are Keen On (ARIA, MACK, GEVA)

    Benzinga
  58. When Cheaper Is Better With ETFs

    Benzinga
  59. Possible Hepatitis C Outbreak Could Lift This ETF

    Benzinga
  60. Low Volume, High Returns for These ETFs (BIB, FHC, DRW)

    Benzinga
  61. Small-Cap Corner: A Forgotten Biotech ETF

    Benzinga
  62. ETFs to Watch July 3, 2012 (TNA, XLB, PCY)

    Benzinga
  63. Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI)

    Benzinga
  64. The Definitive Biotech ETF Guide (IBB, XBI, FBT)

    Benzinga
  65. 4 High P/E ETFs (IBB, IGV, PNQI)

    Benzinga
  66. S&P Bullish On Biotech ETFs (FBT, IBB, XBI)

    Benzinga
  67. 4 Ignored ETFs Up More Than 20% YTD (GERJ, VROM, TAO)

    Benzinga
  68. Viva Vivus, But Not In ETFs (VVUS, IBB, PJP)

    Benzinga
  69. 10 ETFs That Should Lower Their Expense Ratios

    Benzinga
  70. Friday Slide: Opportunity Or Red Flag For Biotech ETFs? (GILD, ...

    Benzinga
  71. ETFs to Watch February 13, 2012

    Benzinga
  72. ETFs to Watch February 8, 2012

    Benzinga
  73. ETFs to Watch January 5, 2012

    Benzinga
  74. Twelve For '12: Sector ETFs to Watch In The New Year

    Benzinga
Trading Center